Reduced dose of imatinib for patients with chronic myeloid leukemia and low body surface area.
about
Efficacy and safety of dasatinib versus imatinib in the East Asian subpopulation of the DASISION trial of newly diagnosed chronic myeloid leukemia in chronic phase.Imatinib plasma trough concentration and its correlation with characteristics and response in Chinese CML patients.Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation.Therapeutic drug monitoring of imatinib for chronic myeloid leukemia patients in the chronic phase.Optimization of radotinib doses for the treatment of Asian patients with chronic myelogenous leukemia based on dose-response relationship analyses.
P2860
Reduced dose of imatinib for patients with chronic myeloid leukemia and low body surface area.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Reduced dose of imatinib for p ...... mia and low body surface area.
@ast
Reduced dose of imatinib for p ...... mia and low body surface area.
@en
type
label
Reduced dose of imatinib for p ...... mia and low body surface area.
@ast
Reduced dose of imatinib for p ...... mia and low body surface area.
@en
prefLabel
Reduced dose of imatinib for p ...... mia and low body surface area.
@ast
Reduced dose of imatinib for p ...... mia and low body surface area.
@en
P2093
P356
P1433
P1476
Reduced dose of imatinib for p ...... mia and low body surface area.
@en
P2093
Byung Soo Kim
Chul Won Choi
Hee Yun Seo
Hwa Jung Sung
In Keun Choi
Jae Hong Seo
Jun Suk Kim
Kyong Hwa Park
Sang Cheul Oh
Sang Won Shin
P304
P356
10.1159/000111777
P577
2007-11-29T00:00:00Z